Oric Pharmaceuticals Inc Rinzimetostat Program Update Call Transcript
Good day and thank you for standing by. Welcome to the ORIC Pharma Update Conference Call. At this time, all participants are in a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask a question during this session, you will need to press *11 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press *11 again. Please be advised that today's conference is being recorded. I would now like to hand the conference over your speaker today. Dominic Pizzitelli, please go ahead, sir.
Welcome to the Auric Pharmaceuticals Rinzimetostat Dose Optimization Data Update Call. Earlier today, we issued a press release highlighting new clinical data and details for our first Phase III trial. We have pre-recorded our prepared remarks, after which we will host a live Q&A session. A replay of the webcast, along with the accompanying slides, will be available on the Investor Relations section of our website for 90 days.
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
